Novartis’ Remibrutinib Delivers Positive Results in Late-Stage MS Studies
Novartis NVS announced positive top-line results from the late-stage REMODEL-1/-2 studies on remibrutinib in relapsing multiple sclerosis (RMS).…
Browsing Tag